BioSpace News Archive

WaveForm Technologies Inc. a wholly owned subsidiary of AgaMatrix Holdings LLC and developer of novel products for continuous glucose monitoring, and A. Menarini Diagnostics S.r.l., a leading diagnostics company, today announced a partnership to commercialize the WaveForm Technologies Continuous Glucose Monitor (CGM).

Amazon announced yesterday that a version of their virtual assistant technology, Alexa, is now HIPAA-eligible.

Mon Ethos Pro Athlete Xavisus Gayden, will travel to Los Angeles, California to compete in the IFBB/NPC Los Angeles Grand Prix event.

Researchers from Ambry Genetics (Ambry), a leading clinical genetics testing company, will present results demonstrating that RNA genetic testing (RGT), as a supplement to DNA genetic testing, improves variant classification in hereditary cancer genetic testing.

NX Prenatal Inc. announced that it has entered into a strategic collaboration with Thermo Fisher Scientific.

Aerpio Pharmaceuticals, Inc. announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the 18th Annual Needham Healthcare Conference on Wednesday, April 10, 2019 at 11:20 a.m. Eastern Time in New York, NY.

Select Medical Holdings Corporation, will release the financial results for its first quarter ended March 31, 2019 on Thursday, May 2, 2019 after the market closes.

Health Canada is advising consumers that several health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, are unauthorized and may pose serious health risks.